Home medical devices are part of the consumer health sector, and the global market has grown steadily in recent years. North America benefits from mature healthcare reimbursement systems, while Asia-Pacific holds major untapped potential. In China, supportive national policies are accelerating the replacement of imported high-end home medical devices with domestic products.

Growing health awareness among people in sub-optimal health, rehabilitation patients, and older adults has increased demand for home medical devices, and the Chinese market was projected to exceed RMB 300 billion by 2026.

Globally, therapeutic devices lead the home medical device market. In China, the market centers on monitoring products such as blood pressure monitors and glucose meters, which have high penetration rates. Influenced by traditional Chinese medicine (TCM), products like cupping sets, gua sha boards, and acupuncture needles also hold a share of the Chinese market.

Chinese manufacturers mainly compete in the mid- to low-end segments and are less competitive in the high-end market. As leading Chinese companies grow and expand exports, China's overall competitiveness in the global market is expected to improve. The industry is transforming around three core trends: online sales, product miniaturization, and smart technology.

This report, based on data available as of 2025, examines the current market landscape, key growth drivers, competitive dynamics, and future opportunities in China's home medical device sector.

Market Size and Growth Potential of China's Home Medical Devices

Rapid Market Expansion

China's aging population has driven strong demand and rapid industry growth. According to BMC Medical's IPO prospectus:

• China's medical device market reached RMB 770.1 billion in 2020, with home medical devices accounting for RMB 239.5 billion (31%).
• By 2025, the total market was projected to reach RMB 1.2945 trillion, with home medical devices rising to RMB 463.8 billion (36%).
• This represents a 14% CAGR for home medical devices, compared with 11% for the overall medical device market and 7% for in-hospital medical imaging equipment.

This makes home medical devices one of the fastest-growing segments in the medical sector.

Main Product Categories

Common home medical devices include:

• Therapeutic devices: far-infrared therapy instruments, magnetic therapy devices
• Monitoring devices: blood pressure monitors, glucose meters, digital thermometers, stethoscopes
• Rehabilitation aids: home oxygen concentrators, cervical and lumbar traction devices, orthotic equipment
• Medical consumables: cotton swabs, gauze, sterilized cotton balls
• Topical products: cooling patches, heat therapy pads

Globally, therapeutic devices hold a 46.9% share of the home medical device market, driven by the rising prevalence of chronic respiratory diseases, higher healthcare spending, and demand for convenient care. In China, monitoring devices lead, with high penetration of blood pressure monitors and glucose meters.

Why Home Medical Devices Are a High-Growth Sector

Rising Net Profit Margins

From 2019 to 2023, the sector's net profit margin (TTM, aggregate method) rose from 14% to 23%, supported by product scaling and new launches. In 2023, it ranked highest among all subsectors in the Shenwan healthcare classification and remained in the top three from 2019 to 2023. Strong brand power creates high barriers to entry, and continued product premiumization is expected to keep profitability at industry-leading levels.

A Fragmented Supply Side Does Not Mean Low Barriers

The market includes many products and manufacturers, with leading listed companies benefiting from channel advantages and diverse portfolios. However, fragmentation does not mean low barriers to entry. Product certification, stability requirements, and premiumization are significant technical hurdles, and brand equity remains a critical competitive advantage.

Premiumization Drives Gross Margins

From 2019 to 2023, the sector's gross margin (aggregate method) rose from 45% to 53%. Key players such as Andon Medical, Yuwell Medical, and Cofoe Medical improved margins through continuous product upgrades. In 2023, the sector's gross margin ranked second in the healthcare industry, staying in the top three from 2020 to 2023.

Brand Power and Economies of Scale

Strong brand recognition speeds up product adoption and scale. Revenue of Chinese home medical device companies shows a high correlation with online follower counts (R² = 0.9789). Building a brand through time, product quality, portfolio breadth, and after-sales service creates lasting competitive advantages.

Long-Term Growth Drivers

Aging Population and Chronic Disease

China's population aged 65 and above was expected to reach 230 million by 2025, with 75% living with chronic diseases. China also has about 140 million people with diabetes and 270 million with hypertension, making home monitoring devices such as glucose meters and oxygen concentrators essential.

Product Premiumization and Smart Technology

From 2019 to 2023, the average adjusted net profit margin of home medical device companies rose from 2.9% to 18%, driven by:

• Scale effects from rapid product adoption
• Higher R&D investment, with average spending growing from RMB 110 million to RMB 280 million, enabling innovation-led premiumization

Policy Support and Healthcare Reform

Since 2022, reforms to personal medical insurance accounts in regions such as Jiangsu, Shanghai, and Lanzhou have expanded coverage to include glucose meters, blood pressure monitors, and thermometers. As more regions adopt similar measures, market penetration is expected to accelerate.

Top 4 Home Medical Device Companies in China

Global manufacturers lead the high-end market with first-mover, technology, and scale advantages. Chinese players, historically focused on mid- to low-end segments, are becoming more competitive through exports and innovation.

BMC Medical: Innovative Home Ventilator Manufacturer

• Patent leadership: won multiple patent disputes against global leader ResMed.
• Regulatory approvals: FDA and CE certified, with products reimbursed in the U.S., Germany, Italy, and Turkey.
• Market share growth: global share rose from 4.5% in 2020 to 17.7% in 2022.

Yuwell Medical: Leading Chinese Home Medical Device Brand

• Market leadership: highest e-commerce follower count and ROE among listed Chinese companies.
• Product launches: introduced 14-day calibration-free continuous glucose monitors (CGM) and began producing AEDs in China in 2023.
• Global expansion: strengthened overseas brand recognition and distribution channels.

Sinocare: Glucose Meter Specialist

• Product leadership: highest share of China's traditional blood glucose monitor (BGM) market; launched CGM systems in 2023.
• Proprietary technology: third-generation direct electron transfer technology for CGMs.
• Global certifications: EU MDR, UK, and Southeast Asian approvals for CGM products.

Cofoe Medical: Diversified Home Device Provider

• Portfolio breadth: health monitoring, rehabilitation aids, respiratory support, medical nursing, and TCM therapy.
• R&D growth: R&D spending increased from RMB 20 million in 2019 to RMB 110 million in 2023.

Key Industry Trends in China

Online Sales Growth

Over 30% of health e-commerce users buy home medical devices on platforms such as Alibaba Health and Tmall Health. Online channels expand market reach, improve transaction efficiency, and enhance the customer experience.

Product Miniaturization

Compact designs, such as portable ventilators and mini glucose meters, suit urban lifestyles with limited living space.

Smart Technology Integration

IoT, big data, and AI enable personalized health management, for example smart glucose meters that sync data to the cloud and telemedicine-enabled devices for real-time physician consultations.

Global Home Medical Device Trends: Lessons from China

The global medical device market reached $612 billion in 2023. Home medical devices account for 25% ($153 billion) and are the fastest-growing segment, at a 7.5% CAGR. By 2030, 14% of the global population will be over 65, fueling demand for chronic disease management and home care.

China's strength in mid-tier devices, such as blood glucose meters (71% share) and portable ventilators, mirrors demand in emerging markets like India and Brazil, where affordability and basic monitoring come first. Developed markets such as the U.S. and Europe focus on premium innovation, such as AI-integrated remote patient monitoring, and strict FDA and CE compliance.

Developed Markets: Premiumization and Smart Technology

North America (38% market share)

• The U.S. leads the $18 billion remote patient monitoring (RPM) sector, with AI-powered tools like Butterfly Network's handheld ultrasound receiving FDA breakthrough status.
• Demand for home dialysis devices is growing at a 9% CAGR, reflecting changing care models.

Europe (30% market share)

• Germany and France lead in rehabilitation robotics, such as ReWalk exoskeletons, while the EU Green Deal encourages recyclable device R&D.
• MDR compliance costs have risen by 30%, putting pressure on smaller players.

Emerging Markets: Accessibility and Localization

China (18% market share)

• The home medical device market is growing at a 14% CAGR, targeting $42 billion by 2026.
• Exports of glucose meters (Yuwell) and oxygen concentrators (BMC Medical) account for 35% of output.
• 12 provinces reimburse glucose meters under public insurance, raising domestic substitution to 70%.

India and Africa

• India: the Ayushman Bharat initiative reduced glucometer prices to $12, raising rural adoption to 40%.
• Africa: Chinese-backed factories, such as portable ventilator plants in Nigeria, are lowering costs, while solar-powered devices address energy gaps.

Other Key Regions

• Latin America: tariff reductions under regional trade agreements helped China-made blood pressure monitors reach 45% market share in Brazil and Mexico.
• Middle East: the UAE's Medical City project is attracting Medtronic and Siemens for local imaging equipment production.

Global Trends Accelerated by China's Growth

• Cost-effective scaling: emerging economies are adopting China's high-volume, low-margin model to expand healthcare access.
• Smart device adoption: IoT and AI in Chinese products, such as Yuwell's cloud-connected monitors, align with global telehealth investment, projected to grow at an 18% CAGR through 2030.
• Regulatory convergence: China's push for international certifications, such as Sinocare's EU MDR-approved CGMs, reflects a global move toward harmonized standards.

Future Outlook

• Emerging markets: Southeast Asia and Africa are likely to follow China's focus on scalable, mid-tier devices, supported by partnerships with Chinese OEMs.
• High-income regions: demand for interoperable, clinic-grade home medical devices, such as AI-driven diagnostics, will grow, with Chinese brands like Andon competing on innovation rather than price.
• Policy synergies: China's Healthy Silk Road initiative could strengthen global supply chains, while climate rules such as the EU CBAM may reshape manufacturing hubs.

China is no longer just the "world's factory." It is becoming a strategic force in expanding access to healthcare worldwide.

Frequently Asked Questions

How do I choose reliable home medical devices?

Focus on certifications (NMPA, formerly CFDA, and FDA), brand reputation, and after-sales support. With over a decade of expertise, MedAsia connects you with factories that meet your exact requirements, delivering quality products and services tailored to your needs.

What are the best-selling home medical devices?

Top sellers include blood glucose meters (71% market share), portable oxygen concentrators, and electronic blood pressure monitors. Explore our product catalog for details.

About MedAsia

MedAsia is dedicated to making healthcare more accessible worldwide by empowering people through self-care. Our goal is to give people everywhere the tools and knowledge to take control of their well-being.

Driven by innovation, MedAsia specializes in self-tests for a range of medical conditions, helping people manage their health conveniently and independently.

Interested in learning more or sourcing home medical devices? Visit our contact page or email info@medasiagroup.com.

Sources

WHO, Frost & Sullivan, BCG, corporate annual reports, Wind, BMC Medical IPO Prospectus, Zheshang Securities Research, Sinocare Annual Reports, Cofoe Medical Financial Reports.